An Exploratory Phase I, Single Centre, Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Study to Assess the Pharmacokinetics of Increasing Oral Doses of AZD5985 in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2009
At a glance
- Drugs AZD 5985 (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 25 Mar 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 25 Mar 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 02 Dec 2008 New trial record.